Allie Strickler

Articles

AR Emerges as a Potential Target in Triple-Negative Breast Cancer

March 24th 2017

Whereas the androgen receptor (AR) is a common target in prostate cancer, emerging findings are showing a potential role for targeting AR in breast cancer, as well.

HER2 Gene Testing Guidelines May Misclassify Patients

March 13th 2017

Michael F. Press, MD, PhD, discusses issues with the ASCO-CAP guidelines on assessment of HER2 amplification by fluorescence in situ hybridization testing.

Expert Discusses Biomarkers for PARP Inhibitors in Ovarian Cancer

February 20th 2017

Dr. Elizabeth Swisher discusses biomarkers for PARP inhibitors and the evolving role of these agents in ovarian cancer.

Mirvetuximab Soravtansine Active in Platinum-Resistant Ovarian Cancer

February 17th 2017

Results of a phase I expansion study demonstrated a manageable safety profile and clinical activity with mirvetuximab soravtansine in the treatment of patients with platinum-resistant ovarian cancer.

Rovalpituzumab Tesirine Active and Safe in Small Cell Lung Cancer

February 13th 2017

Rovalpituzumab tesirine demonstrated encouraging single-agent antitumor activity with a manageable safety profile in the treatment of patients with recurrent small cell lung cancer.

Intentional Weight Loss Linked to Reduction in Endometrial Cancer Risk

February 10th 2017

Intentional weight loss in postmenopausal women has been found to be associated with a lower endometrial cancer risk, particularly among those with obesity, according to the results of a recent study published in the Journal of Clinical Oncology.

Disparities in Cervical Cancer Mortality Rates Highlight Need for Specialized Treatment

February 8th 2017

Anne Rositch, PhD, discusses important takeaways from her study on hysterectomy-corrected mortality rates in cervical cancer and the significance of cervical cancer screening.

Adding Antiandrogen Therapy to Radiation Improves Survival in Recurrent Prostate Cancer

February 6th 2017

The addition of hormonal therapy to radiation treatment following surgery significantly improved survival in patients with recurrent prostate cancer, according to the results of a study published in The New England Journal of Medicine.

Laparoscopy Plays Predictive Role for Primary Surgery Outcomes in Ovarian Cancer

January 28th 2017

Diagnostic laparoscopy reduced the number of futile laparotomies in patients with suspected advanced-stage ovarian cancer, according to the results of a recent study.

New Marker May Identify Men Who Require More Aggressive Prostate Cancer Treatment

January 27th 2017

A prostate-specific antigen nadir greater than 0.5 ng/mL following radiation and androgen deprivation therapy seems to identify men prior to PSA failure who are at high-risk for death, and would thus require more aggressive treatment for their prostate cancer.